Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease.
One week after treatment with intravenously administered immune globulin and aspirin, a child with Kawasaki disease had persistent fever and an increase in coronary artery diameter to greater than 3 mm. Two additional doses of immune globulin were given intravenously. Rapid hemolysis occurred, followed by disseminated intravascular coagulation and serum sickness. Clinicians should be aware that immune globulin preparations contain antibodies to blood-type antigens that may cause significant hemolysis and disseminated intravascular coagulation.
Comenzo
R L
RL
Department of Medicine, New England Medical Center, Boston.
Malachowski
M E
ME
Meissner
H C
HC
Fulton
D R
DR
Berkman
E M
EM
D000017:ABO Blood-Group System / Q000276:immunology; D001241:Aspirin / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000209:etiology*; D006461:Hemolysis / Q000276:immunology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects* / Q000627:therapeutic use; D007223:Infant; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000628:therapy*; D012713:Serum Sickness / Q000209:etiology*
D000017:ABO Blood-Group System; D016756:Immunoglobulins, Intravenous; D001241:Aspirin